Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
24
24 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- Investigational Influenza VaccinePhase 34 trials
BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)
- GP681Phase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- GP681 SimulantPhase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
- Inactivated Polio vaccinePhase 32 trials
LG Chem · Diphtheria, Tetanus, Pertussis
- ZSP1273Phase 32 trials
Guangdong Raynovent Biotech Co., Ltd · Influenza A, Influenza a
- ADC189Phase 31 trial
Jiaxing AnDiCon Biotech Co.,Ltd · Influenza Type A, Influenza Type B
- BK1803Phase 31 trial
Tanabe Pharma Corporation · Pertussis, Diphtheria, Tetanus
- BRC-201TG-1000, Pixavir MarboxilPhase 31 trial
Boryung Biopharma Co., Ltd. · Influenza
- mRNA-1018-H5Phase 31 trial
Moderna · Influenza
- NVXC19EU licensed, standalonePhase 31 trial
Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization
- Flu mRNAGSK6479720A, GSK6498032APhase 22 trials
GSK · Influenza, Human
- Fluzone QudrivalentPhase 22 trials
Sanofi · Healthy Volunteers, Influenza Immunization, Influenza
- rC19Novavax's adjuvanted recombinant COVID-19Phase 22 trials
Sanofi · COVID-19 Immunization, Influenza Immunization
- TRX-100Phase 22 trials
Traws Pharma, Inc. · Influenza
- ApomivirFE-L-APO, drug substancePhase 21 trial
Far East Bio-Tec Co., Ltd · Influenza
- ARCT-2304Phase 21 trial
Arcturus Therapeutics, Inc. · Influenza, Human
- AZD4117Phase 21 trial
AstraZeneca · Influenza A
- AZD5315Phase 21 trial
AstraZeneca · Influenza A
- DL001ZF2G22B, F2H23HPhase 21 trial
GSK · Influenza, Human
- DL001Z-NHF2H23D, F2H23BPhase 21 trial
GSK · Influenza, Human
- GSK5800544APhase 21 trial
GSK · Influenza, Human
- OVX836Phase 21 trial
Osivax · Influenza
- SYH2085Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Influenza
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.